Activated nuclear transcription factor kappaB in patients with myocarditis and dilated cardiomyopathy--relation to

Peter Alter1, Heinz Rupp, Bernhard Maisch

  • 1Philipps University of Marburg, Department of Internal Medicine-Cardiology, Germany. palter@med.uni-marburg.de

Insights

Nuclear factor-kappaB (NFkappaB) activation is elevated in myocarditis, correlating with preserved left ventricular function. This suggests NFkappaB plays a role in early inflammatory stages and may protect against cardiac dilation.

Area of Science:

  • Cardiology
  • Immunology
  • Molecular Biology

Background:

  • Myocarditis, an inflammation of the heart muscle, can be triggered by infections or autoimmune conditions.
  • The role of persistent viral genomes and ongoing adverse processes in myocarditis pathogenesis remains unclear.
  • Nuclear factor-kappaB (NFkappaB) is a key transcription factor implicated in inflammatory and remodeling processes.

Purpose of the Study:

  • To investigate the activation status of NFkappaB in patients with myocarditis and its association with cardiac function and viral persistence.
  • To determine if NFkappaB activation is linked to adverse cardiac remodeling in myocarditis.

Main Methods:

  • Echocardiography and cardiac catheterization were used to assess hemodynamics in 93 patients with suspected myocarditis/cardiomyopathy.
  • Endomyocardial biopsies were analyzed using immunohistochemistry and PCR for viral genomes and activated NFkappaB.
  • Statistical analyses correlated NFkappaB levels with clinical parameters and viral presence.

Main Results:

  • NFkappaB activation was significantly higher in myocarditis patients compared to controls, but not in dilated cardiomyopathy.
  • Increased NFkappaB correlated with preserved left ventricular function and inversely with left ventricular end-diastolic volume.
  • Adenovirus persistence was associated with increased NFkappaB activation, while cytomegalovirus and parvovirus B19 showed no significant association.

Conclusions:

  • Elevated NFkappaB activation is linked to inflammatory processes in myocarditis.
  • NFkappaB activation may occur in early inflammatory stages and potentially protect cardiomyocytes from apoptosis and cardiac dilation.
  • The prognostic and therapeutic relevance of NFkappaB in myocarditis warrants further investigation.
Abstract

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...